FluMist, manufactured by drugmaker AstraZeneca, was previously approved in 2003 for healthcare provider administration, with the new approval allowing for adults to administer the vaccine to themselves or their children, according to a Sept. 20 news release.
However, the vaccine will not be made available for home delivery until the 2025 flu season, as AstraZeneca works with partners to streamline its rollout, CBS News reported Sept. 20. The vaccine is not recommended for pregnant individuals or immunocompromised patients, and the FDA stated that patients will still need to get a prescription for the vaccine from a healthcare provider.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
